Sfoglia per Rivista HAEMATOLOGICA
5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects.
2010-01-01 C., Filì; M., Gobbi; G., Martinelli; C., Finelli; I., Iacobucci; E., Ottaviani; L., Cocco; M., Follo; A., Candoni; E., Simeone; D., Damiani; M., Tiribelli; M., Miglino; F., Lauria; M., Bocchia; M., Defina; C., Clissa; C., Skert; C., Bergonzi; Malagola, Michele; A., Peli; A., Turra; F., Cattina; C., Colombi; Russo, Domenico
A Cooperative Study on the Therapy of Acute Lymphoblastic Leukemia. Results of the Italian Association against Leukemia
1979-01-01 Cesana, Bruno Mario
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients
1992-01-01 Russo, Domenico; Zuffa, E.; Fiacchini, M.; Baccarani, M.
A prospective study of alphaInterferon and autologous bone marrow transplantation in chronic myeloid leukemia
1999-01-01 THE ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID, Leukemia; (WRITING, Committe:; Meloni, G.; Russo, Domenico; Baccarani, M.; Testoni, N.; Martinelli, Giovanna; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.
Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report
2012-01-01 Turra, A; Malagola, M; Bergonzi, C; Skert, C; Filì, C; Perucca, S; Ribolla, R; Cancelli, V; Di Palma, A; Alghisi, E; Cattina, F; Zedda, S; Bernardi, S; Russo, D
Acute myeloid leukemia in the elderly: results obtained with conventional chemotherapy
2000-01-01 Visani, G; Piccaluga, Pp; Isidori, A; Malagola, Michele; Grafone, T; Tura, S.
Advances in prognosis of chronic myeloid leukemia.
1992-01-01 Baccarani, M; Russo, Domenico; Fanin, R; Zuffa, E.; Tura, S.
All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alfa in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines.
1999-01-01 Russo, Domenico; Tell, G.; Marin, L.; Tiribelli, M.; Santucci, M. A.; Pucillo, C.
All-trans retinoic acid in hematological malignancies. An update
1997-01-01 Sacchi, S.; Russo, Domenico; Avvisati, G.; Dastoli, G.; Lazzarino, M.; Pelicci, P. G.; Regazzi Bonora, M.; Visani, G.; Grassi, C.; Iacona, I.; Luzzi, L.; Vanzanelli, P.; on behalf of the, Ger
Allogeneic Stem Cell Transplantation (SCT) for myelodysplastic synromes (MDS) and secondary acute myeloid leukemia. Retrospective study of 32 patients from a single institution.
2003-01-01 Finelli, C; Bonifazi, F; El Cheick, J; Bandini, G; Arpianti, M; Falcioni, S; Stanzani, M; Vigna, E; Malagola, Michele; Rondoni, M; Bosi, C; Piccaluga, Pp; Gaitnai, S; Martinelli, G; Testoni, N; Baccarani, M.
Allogeneic stem cell transplantation after a RIC regimen prolongs the survival in patients with Hodgkin lymphoma relapsed after high-dose chemotherapy: a retrospective study based on donor availability.
2008-01-01 Castagna, L; Sarina, B; Benedetti, F; Milone, G; Patriarca, F; Viviani, S; Malagola, Michele; Ferrari, S; Sorasio, G; Farina, L; Todisco, E; Giordano, L; Corradini, P.
Alpha-interferon as an alternative to allogeneic bone marrow transplantation in the treatment of positive adult acute lymphoblastic leukemia.
2000-01-01 Isidori, A; Visani, G; Martinelli, G; Piccaluga, Pp; Tosi, P; Amabile, M; Pastano, R; Malagola, Michele; Cavo, M; Tura, S.
Alpha-Interferon as maintenance drug after initial Fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma".
1994-01-01 Zinzani, P. L.; Levrero, M. G.; Lauria, F.; Rondelli, D.; Zaja, F.; Russo, Domenico; Fanin, R.; De Rossi, G.; Mauro, F. R.; Bendandi, M.; Gozzetti, A.; Dianzani, F.; Mandelli, F.; Tura, S.
Alpha-L-fucosidasi: possibile marker istochimico per la LLA?
1989-01-01 Nano, R.; Angelini, R.; Rezzani, Rita
Le alterazioni gustative nei trapianti di midollo osseo allogenico per emopatie maligne. Ricerche preliminari
1991-01-01 M. G., Marinone; Rizzoni, Damiano; M. A., Capucci; P., Ferremi; G., Rossi; Paganelli, Corrado; T., Izzi
Analisi dell’impatto della profilassi antifungina in 42 bambini affetti da LLA in terapia
2008-01-01 Guerra, M; Bennato, V; Spinelli, B; Tettoni, K; D'Ippolito, Carmelita; Soresina, R; Notarangelo, L. D.; Brontesi, D; Schumacher, R. F.; Porta, F.
Analysis of the iron status of professional cyclistd during a 3-week road race
1988-01-01 Campanini, S.; Arosio, Paolo; Levi, S.; Ceriotti, F.; Murone, M.; Marconi, C.
Antiangiogenic activity and clinical efficacy of thalidomide in myelodiysplastic syndromes: report of two cases.
2002-01-01 Picaluga, Pp; Finelli, C; Visani, G; Martinelli, G; Grafone, T; Ascani, S; Isidori, A; Malagola, Michele; El Cheich, J; Pileri, Sa; Baccarani, M; Tura, S.
Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers.
2002-01-01 Piccaluga, Pp; Visani, G; Pileri, Sa; Martinelli, G; Finelli, C; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; El cheick, J; Rondoni, M; Baccarani, M; Tura, S.
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
2003-01-01 Martinelli, G; Ottaviani, E; Buonamici, S; Isidori, A; Borsaru, G; Visani, G; Piccaluga, Pp; Malagola, Michele; Testoni, N; Rondoni, M; Nucifora, G; Tura, S; Baccarani, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects. | 1-gen-2010 | C., Filì; M., Gobbi; G., Martinelli; C., Finelli; I., Iacobucci; E., Ottaviani; L., Cocco; M., Follo; A., Candoni; E., Simeone; D., Damiani; M., Tiribelli; M., Miglino; F., Lauria; M., Bocchia; M., Defina; C., Clissa; C., Skert; C., Bergonzi; Malagola, Michele; A., Peli; A., Turra; F., Cattina; C., Colombi; Russo, Domenico | |
| A Cooperative Study on the Therapy of Acute Lymphoblastic Leukemia. Results of the Italian Association against Leukemia | 1-gen-1979 | Cesana, Bruno Mario | |
| A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients | 1-gen-1992 | Russo, Domenico; Zuffa, E.; Fiacchini, M.; Baccarani, M. | |
| A prospective study of alphaInterferon and autologous bone marrow transplantation in chronic myeloid leukemia | 1-gen-1999 | THE ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID, Leukemia; (WRITING, Committe:; Meloni, G.; Russo, Domenico; Baccarani, M.; Testoni, N.; Martinelli, Giovanna; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G. | |
| Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report | 1-gen-2012 | Turra, A; Malagola, M; Bergonzi, C; Skert, C; Filì, C; Perucca, S; Ribolla, R; Cancelli, V; Di Palma, A; Alghisi, E; Cattina, F; Zedda, S; Bernardi, S; Russo, D | |
| Acute myeloid leukemia in the elderly: results obtained with conventional chemotherapy | 1-gen-2000 | Visani, G; Piccaluga, Pp; Isidori, A; Malagola, Michele; Grafone, T; Tura, S. | |
| Advances in prognosis of chronic myeloid leukemia. | 1-gen-1992 | Baccarani, M; Russo, Domenico; Fanin, R; Zuffa, E.; Tura, S. | |
| All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alfa in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines. | 1-gen-1999 | Russo, Domenico; Tell, G.; Marin, L.; Tiribelli, M.; Santucci, M. A.; Pucillo, C. | |
| All-trans retinoic acid in hematological malignancies. An update | 1-gen-1997 | Sacchi, S.; Russo, Domenico; Avvisati, G.; Dastoli, G.; Lazzarino, M.; Pelicci, P. G.; Regazzi Bonora, M.; Visani, G.; Grassi, C.; Iacona, I.; Luzzi, L.; Vanzanelli, P.; on behalf of the, Ger | |
| Allogeneic Stem Cell Transplantation (SCT) for myelodysplastic synromes (MDS) and secondary acute myeloid leukemia. Retrospective study of 32 patients from a single institution. | 1-gen-2003 | Finelli, C; Bonifazi, F; El Cheick, J; Bandini, G; Arpianti, M; Falcioni, S; Stanzani, M; Vigna, E; Malagola, Michele; Rondoni, M; Bosi, C; Piccaluga, Pp; Gaitnai, S; Martinelli, G; Testoni, N; Baccarani, M. | |
| Allogeneic stem cell transplantation after a RIC regimen prolongs the survival in patients with Hodgkin lymphoma relapsed after high-dose chemotherapy: a retrospective study based on donor availability. | 1-gen-2008 | Castagna, L; Sarina, B; Benedetti, F; Milone, G; Patriarca, F; Viviani, S; Malagola, Michele; Ferrari, S; Sorasio, G; Farina, L; Todisco, E; Giordano, L; Corradini, P. | |
| Alpha-interferon as an alternative to allogeneic bone marrow transplantation in the treatment of positive adult acute lymphoblastic leukemia. | 1-gen-2000 | Isidori, A; Visani, G; Martinelli, G; Piccaluga, Pp; Tosi, P; Amabile, M; Pastano, R; Malagola, Michele; Cavo, M; Tura, S. | |
| Alpha-Interferon as maintenance drug after initial Fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma". | 1-gen-1994 | Zinzani, P. L.; Levrero, M. G.; Lauria, F.; Rondelli, D.; Zaja, F.; Russo, Domenico; Fanin, R.; De Rossi, G.; Mauro, F. R.; Bendandi, M.; Gozzetti, A.; Dianzani, F.; Mandelli, F.; Tura, S. | |
| Alpha-L-fucosidasi: possibile marker istochimico per la LLA? | 1-gen-1989 | Nano, R.; Angelini, R.; Rezzani, Rita | |
| Le alterazioni gustative nei trapianti di midollo osseo allogenico per emopatie maligne. Ricerche preliminari | 1-gen-1991 | M. G., Marinone; Rizzoni, Damiano; M. A., Capucci; P., Ferremi; G., Rossi; Paganelli, Corrado; T., Izzi | |
| Analisi dell’impatto della profilassi antifungina in 42 bambini affetti da LLA in terapia | 1-gen-2008 | Guerra, M; Bennato, V; Spinelli, B; Tettoni, K; D'Ippolito, Carmelita; Soresina, R; Notarangelo, L. D.; Brontesi, D; Schumacher, R. F.; Porta, F. | |
| Analysis of the iron status of professional cyclistd during a 3-week road race | 1-gen-1988 | Campanini, S.; Arosio, Paolo; Levi, S.; Ceriotti, F.; Murone, M.; Marconi, C. | |
| Antiangiogenic activity and clinical efficacy of thalidomide in myelodiysplastic syndromes: report of two cases. | 1-gen-2002 | Picaluga, Pp; Finelli, C; Visani, G; Martinelli, G; Grafone, T; Ascani, S; Isidori, A; Malagola, Michele; El Cheich, J; Pileri, Sa; Baccarani, M; Tura, S. | |
| Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers. | 1-gen-2002 | Piccaluga, Pp; Visani, G; Pileri, Sa; Martinelli, G; Finelli, C; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; El cheick, J; Rondoni, M; Baccarani, M; Tura, S. | |
| Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. | 1-gen-2003 | Martinelli, G; Ottaviani, E; Buonamici, S; Isidori, A; Borsaru, G; Visani, G; Piccaluga, Pp; Malagola, Michele; Testoni, N; Rondoni, M; Nucifora, G; Tura, S; Baccarani, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile